Literature DB >> 31676679

Correction: Upregulation of PD-L1 via HMGB1-Activated IRF3 and NF-κB Contributes to UV Radiation-Induced Immune Suppression.

Wei Wang, Nicole M Chapman, Bo Zhang, Mingqi Li, Meiyun Fan, R Nicholas Laribee, M Raza Zaidi, Lawrence M Pfeffer, Hongbo Chi, Zhao-Hui Wu.   

Abstract

Entities:  

Year:  2019        PMID： 31676679     DOI： 10.1158/0008-5472.CAN-19-2862

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  3 in total

1.  HMGB1 mediates invasion and PD-L1 expression through RAGE-PI3K/AKT signaling pathway in MDA-MB-231 breast cancer cells.

Authors:  Kamolporn Amornsupak; Suyanee Thongchot; Chanida Thinyakul; Carol Box; Somaieh Hedayat; Peti Thuwajit; Suzanne A Eccles; Chanitra Thuwajit
Journal:  BMC Cancer       Date:  2022-05-24       Impact factor: 4.638

2.  EPHA5 mutations predict survival after immunotherapy in lung adenocarcinoma.

Authors:  Zhiming Chen; Ji Chen; Dandan Ren; Jiao Zhang; Ying Yang; Henghui Zhang; Beibei Mao; Haitao Ma
Journal:  Aging (Albany NY)       Date:  2020-12-03       Impact factor: 5.682

3.  HMGB1 is a key factor for tamoxifen resistance and has the potential to predict the efficacy of CDK4/6 inhibitors in breast cancer.

Authors:  Han Zhang; Jinlu Wang; Jingtong Li; Xiaoping Zhou; Lei Yin; Yiran Wang; Yucui Gu; Xingjian Niu; Yue Yang; Hongfei Ji; Qingyuan Zhang
Journal:  Cancer Sci       Date:  2021-02-26       Impact factor: 6.716
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.